http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-77063-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdd938ec7e5671015cc29730b51ec847 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568 |
| filingDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f18eb2ce0ba9326e49236dde207dfe9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dbb51519b759acec3f6dd6a7f42d6cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a6f033ac737a2613358bf961b8c8788 |
| publicationDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-77063-U |
| titleOfInvention | METHOD FOR TREATING ERECTILE DYSFUNCTION IN MEN WITH TYPE 2 DIABETES |
| abstract | A method of treating erectile dysfunction in men with type 2 diabetes involves the use of type 5 phosphodiesterase inhibitors. The patient is prescribed substitute testosterone therapy and, after reaching the level of total testosterone in the serum on an empty stomach 12-16 nmol / l, add a phosphodiesterase type 5 inhibitor, such as vardenafil, and additionally a preparation containing the amino acid L-arginine, such as ezerex. |
| priorityDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.